|
Volumn 60, Issue 7, 2011, Pages
|
To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINO ACID;
APELIN;
APELIN 36;
APROTININ;
BENZYLSULFONYL FLUORIDE;
CASPASE;
GAMMA GLUTAMYLTRANSFERASE;
KALLIKREIN INHIBITOR;
OBESTATIN;
PROTEINASE INHIBITOR;
UNCLASSIFIED DRUG;
VASPIN;
APOPTOSIS;
BIOCHEMISTRY;
BLOOD ANALYSIS;
DISEASE COURSE;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
GASTROINTESTINAL TRACT;
HORMONE BLOOD LEVEL;
HUMAN;
LETTER;
LIVER CIRRHOSIS;
NONALCOHOLIC FATTY LIVER;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
TUBE;
FATTY LIVER;
GHRELIN;
HUMANS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
PROTEASE INHIBITORS;
SERPINS;
|
EID: 79959357939
PISSN: 00260495
EISSN: 15328600
Source Type: Journal
DOI: 10.1016/j.metabol.2011.01.015 Document Type: Letter |
Times cited : (2)
|
References (6)
|